U.S. Markets closed

How Khiron Life Sciences Corp. (CVE:KHRN) Could Add Value To Your Portfolio

Simply Wall St

I've been keeping an eye on Khiron Life Sciences Corp. (CVE:KHRN) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe KHRN has a lot to offer. Basically, it is a company with strong financial health as well as an optimistic future outlook. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on Khiron Life Sciences here.

Exceptional growth potential with excellent balance sheet

KHRN is an attractive stock for growth-seeking investors, with an expected earnings growth of 78% in the upcoming year. Earnings growth is paired with an eye-catching top-line trajectory also doubling over the same period, which indicates a high-quality bottom-line expansion, as opposed to those driven by unsustainable cost-cutting activities. KHRN's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This indicates that KHRN has sufficient cash flows and proper cash management in place, which is a crucial insight into the health of the company. KHRN’s debt-to-equity ratio stands at 5.3%, which means its debt level is reasonable. This implies that KHRN has a healthy balance between taking advantage of low cost debt funding as well as sufficient financial flexibility without succumbing to the strict terms of debt.

TSXV:KHRN Past and Future Earnings, August 20th 2019

Next Steps:

For Khiron Life Sciences, I've compiled three key aspects you should look at:

  1. Historical Performance: What has KHRN's returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
  2. Valuation: What is KHRN worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether KHRN is currently mispriced by the market.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of KHRN? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.